NCT06262594View on ClinicalTrials.gov

Lemborexant Treatment of Insomnia Linked to Epilepsy

PHASE3RecruitingINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

October 29, 2024

Primary Completion Date

April 18, 2026

Study Completion Date

April 18, 2027

Conditions

EpilepsySleep

Interventions

DRUG

Lemborexant

Drug is administered

DRUG

Placebo

Drug is administered

Trial Locations (2)

27708

NOT_YET_RECRUITING

Duke University, Durham

R3A1R9

RECRUITING

Health Sciences Centre, Winnipeg

Sponsors

Collaborators (1)

Duke University

All Listed Sponsors

collaborator

Duke University

OTHER

lead

University of Manitoba

OTHER

NCT06262594 - Lemborexant Treatment of Insomnia Linked to Epilepsy | Biotech Hunter | Biotech Hunter